325 related articles for article (PubMed ID: 38162229)
1. Microphysiological systems as reliable drug discovery and evaluation tools: Evolution from innovation to maturity.
Moon HR; Surianarayanan N; Singh T; Han B
Biomicrofluidics; 2023 Dec; 17(6):061504. PubMed ID: 38162229
[TBL] [Abstract][Full Text] [Related]
2. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
4. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
Hargrove-Grimes P; Low LA; Tagle DA
Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
[TBL] [Abstract][Full Text] [Related]
5. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
Kimura H
Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
7. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
8. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
9. Microphysiological Constructs and Systems: Biofabrication Tactics, Biomimetic Evaluation Approaches, and Biomedical Applications.
Zhang S; Xu G; Wu J; Liu X; Fan Y; Chen J; Wallace G; Gu Q
Small Methods; 2024 Jan; 8(1):e2300685. PubMed ID: 37798902
[TBL] [Abstract][Full Text] [Related]
10. Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and
Yoon S; Kilicarslan You D; Jeong U; Lee M; Kim E; Jeon TJ; Kim SM
Biosensors (Basel); 2024 Jan; 14(1):. PubMed ID: 38275308
[TBL] [Abstract][Full Text] [Related]
11. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
Low LA; Tagle DA
Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
[TBL] [Abstract][Full Text] [Related]
12. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
[TBL] [Abstract][Full Text] [Related]
13. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS).
Ueno R; Kuninori M; Sumi T; Sadeghian RB; Takata Y; Iguchi A; Tsuda M; Yamashita F; Ichikawa K; Yokokawa R
Micromachines (Basel); 2023 Mar; 14(4):. PubMed ID: 37420994
[TBL] [Abstract][Full Text] [Related]
15. Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications.
Castiglione H; Vigneron PA; Baquerre C; Yates F; Rontard J; Honegger T
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365119
[TBL] [Abstract][Full Text] [Related]
16. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS).
Malik M; Yang Y; Fathi P; Mahler GJ; Esch MB
Front Cell Dev Biol; 2021; 9():721338. PubMed ID: 34568333
[TBL] [Abstract][Full Text] [Related]
17. Emerging trends in organ-on-a-chip systems for drug screening.
Wang Y; Gao Y; Pan Y; Zhou D; Liu Y; Yin Y; Yang J; Wang Y; Song Y
Acta Pharm Sin B; 2023 Jun; 13(6):2483-2509. PubMed ID: 37425038
[TBL] [Abstract][Full Text] [Related]
18. Imaging microphysiological systems: a review.
Peel S; Jackman M
Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
[TBL] [Abstract][Full Text] [Related]
19. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
Donoghue L; Nguyen KT; Graham C; Sethu P
Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
[TBL] [Abstract][Full Text] [Related]
20. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
